financial results

CBD of Denver, Inc. (OTC:CBDD) has filed its financial results for the year ended Dec. 31, 2023. The Colorado-based cannabis company said total current assets increased to $117,218 in 2023, up from $28,043 in 2022. Gross profit for the year totaled $595,417, representing a significant recovery from...

Psychedelics healthcare company Numinus Wellness (OTCQX:NUMIF) shared its unaudited, condensed and consolidated interim financial results for the three and six months ended February 29, 2024.  Q2 showed: Cash position of $4.8 (CA$6.6) million by February 29, 2024, compared to the $14.33...

Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) reported its financial results Monday for the three and 12 months ended Nov. 30, 2023. The Toronto-based company noted it had achieved the highest quarterly gross profit in the company's history in the fourth quarter totaling CA$2...

Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN), the cannabinoids-focused biopharmaceutical company reported its year-end 2023 results and audited financial statements on Tuesday. The Canadian company reported CA$16.8 million ($12.3 million) in total revenue, up by 314% year-over-year. Avicanna...

Clinical-stage psychedelics biotech Atai Life Sciences (NASDAQ:ATAI) announced its consolidated financial results for the fourth quarter and full year 2023. The Numbers: Cash, cash equivalents and short-term investments of $154.2 million by December 31, 2023, as compared to $273.1 million by...

Hemp-focused CV Sciences, Inc. (OTCQB:CVSI) announced its financial results on Thursday for the year ended Dec. 31, 2023. The San Diego-based company reported a gross margin of 44.3% for fiscal year 2023, representing an improvement from 34.2% for 2022. For the fourth quarter, its gross margin was...

MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the full year and three months ended Dec. 31, 2023. Net revenue grew to CA$33 million ($24.3 million) in 2023, from CA$22.1 million in 2022, representing roughly a 50% year-over-year increase,...

Nasdaq-listed psychedelics biotech Enveric Biosciences (NASDAQ:ENVB) shared its financial results for the fourth quarter of 2023 and the fiscal year ended December 31, 2023, results showing: Cash in hand of $2,287,977 by December 31, 2023, as compared to the $17,723,884 held by December 31, 2022....

Body and Mind Inc. (CSE:BAMM) (OTCQB:BMMJ) announced its financial results on Tuesday for the second quarter of fiscal year 2024 ended Jan. 31, 2024, revealing a 94% year-over-year drop in net loss. The company said that during the quarter it has entered into a definitive agreement to divest its...

Charlotte’s Web Holdings, Inc. (TSX:CWEB) (OTCQX:CWBHF) reported its financial results on Thursday for the fourth quarter and year ended Dec. 31, 2023. The Colorado-based hemp extract wellness producer reported a 16% year-over-year decrease in fourth-quarter consolidated net revenue to $15.9...

SNDL Inc. (NASDAQ:SNDL) reported on Thursday its financial and operational results for the full year and fourth quarter ended Dec. 31, 2023, revealing a record net revenue for 2023 of CA$909 million ($670.3 million) compared to CA$712.2 million in 2022. That's an increase of 28% year-over-year. The...

Maker of Zig-Zag rolling paper Turning Point Brands, Inc. (NYSE:TPB) announced its financial results on Wednesday for the fourth quarter and full year ended Dec. 31, 2023. Graham Purdy, president and CEO, praised the quarterly results.  "Our fourth quarter results were at the high end of our...

Psychedelics mental healthcare company Numinus Wellness (OTCQX: NUMIF) posted its financial results for the three months ended Nov. 30, 2023. Q1 numbers show: Cash position of $3.5 (CA$4.7) million by Nov. 30, 2023, vs. $6.35 million held by August 31 (immediately prior fiscal quarter...

Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) reported a 34% year-over-year revenue increase Tuesday for the second quarter of fiscal 2024, to $194 million. "Our Q2 financial results demonstrate the strength of our brands, our global team, and our diversified growth strategy," Irwin D. Simon,...

cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) reported its quarterly and full fiscal financial results on Friday for Sept. 30, 2023, revealing a 27% year-over-year drop in fourth-quarter net sales to $5.7 million. The company attributed the revenue decline to "industry trends, a reduction of marketing spend...